APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rituximab Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rituximab Injection Industry Growth and Trends Forecast to 2032

22 December 2025116 pages

Choose your research edition.

Industry ResearchRituximab Injection Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Rituximab Injection Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Rituximab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rituximab Injection Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Rituximab Injection Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Rituximab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rituximab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rituximab Injection include Innovent Biologics, Roche, Pfizer, Fosun-Pharmaceutical, Shanghai Henlius Biotech, Amgen, Zenotech Laboratories, TRPharma and Probiomed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rituximab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rituximab Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rituximab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rituximab Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rituximab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rituximab Injection Market by Company

Innovent Biologics

Roche

Pfizer

Fosun-Pharmaceutical

Shanghai Henlius Biotech

Amgen

Zenotech Laboratories

TRPharma

Probiomed

Lexicare Pharma

Kavya Pharma

Intas Pharmaceuticals

Hetero Group

Healthiza Lifescience

Dr Reddy’s Laboratories

Celltrion

Cadila Pharmaceuticals

Rituximab Injection Segment by Type

100 ml

500 ml

Rituximab Injection Segment by Application

Hospitals

Clinics

Others

Rituximab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rituximab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rituximab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rituximab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rituximab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rituximab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100 ml Table 2. Major Company of 500 ml Table 3. Global Rituximab Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rituximab Injection Sales by Type (2021-2026) & (k units) Table 5. Global Rituximab Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rituximab Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Rituximab Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Rituximab Injection Sales by Type (2027-2032) & (k units) Table 10. Global Rituximab Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rituximab Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rituximab Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Rituximab Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Rituximab Injection Sales by Type (2021-2026) & (k units) Table 15. North America Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rituximab Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rituximab Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rituximab Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rituximab Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Rituximab Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Rituximab Injection Industry Trends Table 25. Rituximab Injection Industry Drivers Table 26. Rituximab Injection Industry Opportunities and Challenges Table 27. Rituximab Injection Industry Restraints Table 28. Global Rituximab Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rituximab Injection Revenue Market Share by Company (2021-2026) Table 30. Global Rituximab Injection Sales by Company (2021-2026) & (k units) Table 31. Global Rituximab Injection Sales Share by Company (2021-2026) Table 32. Global Rituximab Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Rituximab Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rituximab Injection Major Company Production Sites and Headquarters Table 35. Global Rituximab Injection Company, Product Type & Application Table 36. Global Rituximab Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rituximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rituximab Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rituximab Injection Sales by Region (2021-2026) & (k units) Table 41. Global Rituximab Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rituximab Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rituximab Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Rituximab Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Rituximab Injection Sales by Region (2027-2032) & (k units) Table 46. Global Rituximab Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rituximab Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rituximab Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Rituximab Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Rituximab Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rituximab Injection Sales by Application (2021-2026) & (k units) Table 52. Global Rituximab Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rituximab Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Rituximab Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Rituximab Injection Sales by Application (2027-2032) & (k units) Table 57. Global Rituximab Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rituximab Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rituximab Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Rituximab Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Rituximab Injection Sales by Application (2021-2026) & (k units) Table 62. North America Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rituximab Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rituximab Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rituximab Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rituximab Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Rituximab Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Innovent Biologics Company Information Table 72. Innovent Biologics Business Overview Table 73. Innovent Biologics Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Innovent Biologics Rituximab Injection Product Portfolio Table 75. Innovent Biologics Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Roche Rituximab Injection Product Portfolio Table 80. Roche Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Rituximab Injection Product Portfolio Table 85. Pfizer Recent Development Table 86. Fosun-Pharmaceutical Company Information Table 87. Fosun-Pharmaceutical Business Overview Table 88. Fosun-Pharmaceutical Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Fosun-Pharmaceutical Rituximab Injection Product Portfolio Table 90. Fosun-Pharmaceutical Recent Development Table 91. Shanghai Henlius Biotech Company Information Table 92. Shanghai Henlius Biotech Business Overview Table 93. Shanghai Henlius Biotech Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Shanghai Henlius Biotech Rituximab Injection Product Portfolio Table 95. Shanghai Henlius Biotech Recent Development Table 96. Amgen Company Information Table 97. Amgen Business Overview Table 98. Amgen Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Amgen Rituximab Injection Product Portfolio Table 100. Amgen Recent Development Table 101. Zenotech Laboratories Company Information Table 102. Zenotech Laboratories Business Overview Table 103. Zenotech Laboratories Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Zenotech Laboratories Rituximab Injection Product Portfolio Table 105. Zenotech Laboratories Recent Development Table 106. TRPharma Company Information Table 107. TRPharma Business Overview Table 108. TRPharma Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. TRPharma Rituximab Injection Product Portfolio Table 110. TRPharma Recent Development Table 111. Probiomed Company Information Table 112. Probiomed Business Overview Table 113. Probiomed Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Probiomed Rituximab Injection Product Portfolio Table 115. Probiomed Recent Development Table 116. Lexicare Pharma Company Information Table 117. Lexicare Pharma Business Overview Table 118. Lexicare Pharma Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Lexicare Pharma Rituximab Injection Product Portfolio Table 120. Lexicare Pharma Recent Development Table 121. Kavya Pharma Company Information Table 122. Kavya Pharma Business Overview Table 123. Kavya Pharma Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Kavya Pharma Rituximab Injection Product Portfolio Table 125. Kavya Pharma Recent Development Table 126. Intas Pharmaceuticals Company Information Table 127. Intas Pharmaceuticals Business Overview Table 128. Intas Pharmaceuticals Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Intas Pharmaceuticals Rituximab Injection Product Portfolio Table 130. Intas Pharmaceuticals Recent Development Table 131. Hetero Group Company Information Table 132. Hetero Group Business Overview Table 133. Hetero Group Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Hetero Group Rituximab Injection Product Portfolio Table 135. Hetero Group Recent Development Table 136. Healthiza Lifescience Company Information Table 137. Healthiza Lifescience Business Overview Table 138. Healthiza Lifescience Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Healthiza Lifescience Rituximab Injection Product Portfolio Table 140. Healthiza Lifescience Recent Development Table 141. Dr Reddy’s Laboratories Company Information Table 142. Dr Reddy’s Laboratories Business Overview Table 143. Dr Reddy’s Laboratories Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Dr Reddy’s Laboratories Rituximab Injection Product Portfolio Table 145. Dr Reddy’s Laboratories Recent Development Table 146. Celltrion Company Information Table 147. Celltrion Business Overview Table 148. Celltrion Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Celltrion Rituximab Injection Product Portfolio Table 150. Celltrion Recent Development Table 151. Cadila Pharmaceuticals Company Information Table 152. Cadila Pharmaceuticals Business Overview Table 153. Cadila Pharmaceuticals Rituximab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Cadila Pharmaceuticals Rituximab Injection Product Portfolio Table 155. Cadila Pharmaceuticals Recent Development Table 156. North America Rituximab Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. North America Rituximab Injection Sales by Country (2021-2026) & (k units) Table 158. North America Rituximab Injection Sales Market Share by Country (2021-2026) Table 159. North America Rituximab Injection Sales Forecast by Country (2027-2032) & (k units) Table 160. North America Rituximab Injection Sales Market Share Forecast by Country (2027-2032) Table 161. North America Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Rituximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Rituximab Injection Market Share by Country (2021-2026) Table 164. North America Rituximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Rituximab Injection Market Share Forecast by Country (2027-2032) Table 166. Europe Rituximab Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Europe Rituximab Injection Sales by Country (2021-2026) & (k units) Table 168. Europe Rituximab Injection Sales Market Share by Country (2021-2026) Table 169. Europe Rituximab Injection Sales Forecast by Country (2027-2032) & (k units) Table 170. Europe Rituximab Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Rituximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Rituximab Injection Market Share by Country (2021-2026) Table 174. Europe Rituximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Rituximab Injection Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Rituximab Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Rituximab Injection Sales by Country (2021-2026) & (k units) Table 178. Asia-Pacific Rituximab Injection Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Rituximab Injection Sales Forecast by Country (2027-2032) & (k units) Table 180. Asia-Pacific Rituximab Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Rituximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Rituximab Injection Market Share by Country (2021-2026) Table 184. Asia-Pacific Rituximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Rituximab Injection Market Share Forecast by Country (2027-2032) Table 186. Latin America Rituximab Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Latin America Rituximab Injection Sales by Country (2021-2026) & (k units) Table 188. Latin America Rituximab Injection Sales Market Share by Country (2021-2026) Table 189. Latin America Rituximab Injection Sales Forecast by Country (2027-2032) & (k units) Table 190. Latin America Rituximab Injection Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Rituximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Rituximab Injection Market Share by Country (2021-2026) Table 194. Latin America Rituximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Rituximab Injection Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Rituximab Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Rituximab Injection Sales by Country (2021-2026) & (k units) Table 198. Middle East and Africa Rituximab Injection Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Rituximab Injection Sales Forecast by Country (2027-2032) & (k units) Table 200. Middle East and Africa Rituximab Injection Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Rituximab Injection Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Rituximab Injection Market Share by Country (2021-2026) Table 204. Middle East and Africa Rituximab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Rituximab Injection Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Rituximab Injection Distributors List Table 209. Rituximab Injection Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Rituximab Injection Image Figure 2. Global Rituximab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rituximab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Rituximab Injection Sales (2021-2032) & (k units) Figure 5. 100 ml Image Figure 6. Global 100 ml Sales YoY Growth (2021-2032) & (k units) Figure 7. 500 ml Image Figure 8. Global 500 ml Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Rituximab Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rituximab Injection Market Share by Type 2025 VS 2032 Figure 11. North America Rituximab Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Rituximab Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Rituximab Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rituximab Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rituximab Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rituximab Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rituximab Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rituximab Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rituximab Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rituximab Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Rituximab Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rituximab Injection Market Share by Application 2025 VS 2032 Figure 31. North America Rituximab Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Rituximab Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Rituximab Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rituximab Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rituximab Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rituximab Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rituximab Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rituximab Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rituximab Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rituximab Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Rituximab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Rituximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rituximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rituximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rituximab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Rituximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rituximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rituximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rituximab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Rituximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rituximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rituximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rituximab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Rituximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rituximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rituximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rituximab Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Rituximab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rituximab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rituximab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rituximab Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rituximab Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100 ml
  • 500 ml
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Innovent Biologics
  • Roche
  • Pfizer
  • Fosun-Pharmaceutical
  • Shanghai Henlius Biotech
  • Amgen
  • Zenotech Laboratories
  • TRPharma
  • Probiomed
  • Lexicare Pharma
  • Kavya Pharma
  • Intas Pharmaceuticals
  • Hetero Group
  • Healthiza Lifescience
  • Dr Reddy’s Laboratories
  • Celltrion
  • Cadila Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rituximab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rituximab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rituximab Injection Market by Type
  6. 1.3.1 100 ml
  7. 1.3.2 500 ml
  8. 1.4 Global Rituximab Injection Market Size by Type
  9. 1.4.1 Global Rituximab Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rituximab Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rituximab Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rituximab Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rituximab Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rituximab Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rituximab Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rituximab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rituximab Injection Industry Trends
  2. 2.2 Rituximab Injection Industry Drivers
  3. 2.3 Rituximab Injection Industry Opportunities and Challenges
  4. 2.4 Rituximab Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rituximab Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Rituximab Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Rituximab Injection Price (2021-2026)
  4. 3.4 Global Rituximab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rituximab Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Rituximab Injection Company, Product Type & Application
  7. 3.7 Global Rituximab Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rituximab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rituximab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rituximab Injection Tier 1, Tier 2, and Tier 3
4 Rituximab Injection Regional Status and Outlook
  1. 4.1 Global Rituximab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rituximab Injection Historic Market Size by Region
  3. 4.2.1 Global Rituximab Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rituximab Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rituximab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rituximab Injection Forecasted Market Size by Region
  7. 4.3.1 Global Rituximab Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rituximab Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rituximab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rituximab Injection by Application
  1. 5.1 Rituximab Injection Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Rituximab Injection Market Size by Application
  6. 5.2.1 Global Rituximab Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rituximab Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rituximab Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rituximab Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rituximab Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rituximab Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rituximab Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rituximab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Innovent Biologics
  2. 6.1.1 Innovent Biologics Company Information
  3. 6.1.2 Innovent Biologics Business Overview
  4. 6.1.3 Innovent Biologics Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Innovent Biologics Rituximab Injection Product Portfolio
  6. 6.1.5 Innovent Biologics Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Rituximab Injection Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Rituximab Injection Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Fosun-Pharmaceutical
  20. 6.4.1 Fosun-Pharmaceutical Company Information
  21. 6.4.2 Fosun-Pharmaceutical Business Overview
  22. 6.4.3 Fosun-Pharmaceutical Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fosun-Pharmaceutical Rituximab Injection Product Portfolio
  24. 6.4.5 Fosun-Pharmaceutical Recent Developments
  25. 6.5 Shanghai Henlius Biotech
  26. 6.5.1 Shanghai Henlius Biotech Company Information
  27. 6.5.2 Shanghai Henlius Biotech Business Overview
  28. 6.5.3 Shanghai Henlius Biotech Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Henlius Biotech Rituximab Injection Product Portfolio
  30. 6.5.5 Shanghai Henlius Biotech Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Amgen Rituximab Injection Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 Zenotech Laboratories
  38. 6.7.1 Zenotech Laboratories Company Information
  39. 6.7.2 Zenotech Laboratories Business Overview
  40. 6.7.3 Zenotech Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zenotech Laboratories Rituximab Injection Product Portfolio
  42. 6.7.5 Zenotech Laboratories Recent Developments
  43. 6.8 TRPharma
  44. 6.8.1 TRPharma Company Information
  45. 6.8.2 TRPharma Business Overview
  46. 6.8.3 TRPharma Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 TRPharma Rituximab Injection Product Portfolio
  48. 6.8.5 TRPharma Recent Developments
  49. 6.9 Probiomed
  50. 6.9.1 Probiomed Company Information
  51. 6.9.2 Probiomed Business Overview
  52. 6.9.3 Probiomed Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Probiomed Rituximab Injection Product Portfolio
  54. 6.9.5 Probiomed Recent Developments
  55. 6.10 Lexicare Pharma
  56. 6.10.1 Lexicare Pharma Company Information
  57. 6.10.2 Lexicare Pharma Business Overview
  58. 6.10.3 Lexicare Pharma Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lexicare Pharma Rituximab Injection Product Portfolio
  60. 6.10.5 Lexicare Pharma Recent Developments
  61. 6.11 Kavya Pharma
  62. 6.11.1 Kavya Pharma Company Information
  63. 6.11.2 Kavya Pharma Business Overview
  64. 6.11.3 Kavya Pharma Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kavya Pharma Rituximab Injection Product Portfolio
  66. 6.11.5 Kavya Pharma Recent Developments
  67. 6.12 Intas Pharmaceuticals
  68. 6.12.1 Intas Pharmaceuticals Company Information
  69. 6.12.2 Intas Pharmaceuticals Business Overview
  70. 6.12.3 Intas Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Intas Pharmaceuticals Rituximab Injection Product Portfolio
  72. 6.12.5 Intas Pharmaceuticals Recent Developments
  73. 6.13 Hetero Group
  74. 6.13.1 Hetero Group Company Information
  75. 6.13.2 Hetero Group Business Overview
  76. 6.13.3 Hetero Group Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hetero Group Rituximab Injection Product Portfolio
  78. 6.13.5 Hetero Group Recent Developments
  79. 6.14 Healthiza Lifescience
  80. 6.14.1 Healthiza Lifescience Company Information
  81. 6.14.2 Healthiza Lifescience Business Overview
  82. 6.14.3 Healthiza Lifescience Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Healthiza Lifescience Rituximab Injection Product Portfolio
  84. 6.14.5 Healthiza Lifescience Recent Developments
  85. 6.15 Dr Reddy’s Laboratories
  86. 6.15.1 Dr Reddy’s Laboratories Company Information
  87. 6.15.2 Dr Reddy’s Laboratories Business Overview
  88. 6.15.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr Reddy’s Laboratories Rituximab Injection Product Portfolio
  90. 6.15.5 Dr Reddy’s Laboratories Recent Developments
  91. 6.16 Celltrion
  92. 6.16.1 Celltrion Company Information
  93. 6.16.2 Celltrion Business Overview
  94. 6.16.3 Celltrion Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Celltrion Rituximab Injection Product Portfolio
  96. 6.16.5 Celltrion Recent Developments
  97. 6.17 Cadila Pharmaceuticals
  98. 6.17.1 Cadila Pharmaceuticals Company Information
  99. 6.17.2 Cadila Pharmaceuticals Business Overview
  100. 6.17.3 Cadila Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Cadila Pharmaceuticals Rituximab Injection Product Portfolio
  102. 6.17.5 Cadila Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Rituximab Injection Sales by Country
  2. 7.1.1 North America Rituximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rituximab Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Rituximab Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rituximab Injection Market Size by Country
  6. 7.2.1 North America Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rituximab Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Rituximab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rituximab Injection Sales by Country
  2. 8.1.1 Europe Rituximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rituximab Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Rituximab Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rituximab Injection Market Size by Country
  6. 8.2.1 Europe Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rituximab Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rituximab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rituximab Injection Sales by Country
  2. 9.1.1 Asia-Pacific Rituximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rituximab Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rituximab Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rituximab Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rituximab Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rituximab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rituximab Injection Sales by Country
  2. 10.1.1 South America Rituximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rituximab Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Rituximab Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rituximab Injection Market Size by Country
  6. 10.2.1 South America Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rituximab Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Rituximab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rituximab Injection Sales by Country
  2. 11.1.1 Middle East and Africa Rituximab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rituximab Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rituximab Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rituximab Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Rituximab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rituximab Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rituximab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rituximab Injection Value Chain Analysis
  2. 12.1.1 Rituximab Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rituximab Injection Production Mode & Process
  7. 12.2 Rituximab Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rituximab Injection Distributors
  10. 12.2.3 Rituximab Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst